A question which I will raise with Esra when I have the opportunity:
Assuming that CSL is satisfied with the results of recent and ongoing research, and assuming further that TPM is completely successful in demonstrating effective delivery of say, influenza vaccine, what's the subsequent time frame to commercialization?
Could this be relatively quick to market? The patch would not need to deal with any long term irritation issues: presumably it would be a one or two day active delivery. Obviously, vaccines do not require years of efficacy and safety trials; if they did they would not be available when needed.
Any thoughts by resident experts?
POH Price at posting:
12.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)